General | 07 November 2020
Ajanta Pharma completes acquisition of Eugia Pharma
The acquisition was completed on November 6, 2020
The acquisition was completed on November 6, 2020
The minister said that LNG is a fuel of the future, and its cost benefit and other advantages over other fuels must be communicated in an aggressive and specific manner
For the quarter ended September 30, 2020, on a standalone basis, CFCL achieved revenue of Rs. 3,986.94 crore
The growth in revenue is due to the higher offtake of existing products and new market opportunities
Electronics Technology Center will focus on semiconductor and OLED materials
The project study comprised a world-scale propane dehydrogenation (PDH) plant, a polypropylene (PP) production and an acrylics value chain complex
Company partners with a key United Nations Environment Programme project to accelerate the phase-out of lead in paints
Artificial intelligence and machine learning allow reliable analysis of diseases and pests in worldwide field trials
According to the company, the incident is currently not material and has not impacted its core systems and operations
Pierre-Alain Ruffieux has joined as Chief Executive Officer of the company
Expansion is based on a tailored business agreement with a major biopharmaceutical partner that ensures ADC payload supply continuity and flexibility
Supported and backed by Invest India, Startup India, TiE Global and other partners, the program is a part of IESA’s 5-day long virtual conference and exhibition - India Energy Storage Week (IESW), focusing on energy storage, EV and microgrids
65% business has already been booked in first two quarters and the overall target is quite attainable as per the company
Company has appointed Rupark Sarswat as Chief Executive Officer
Shift to global business unit-led structure expected to accelerate decision making, increase accountability and improve execution
Citing examples with crop production statistics from the Aligarh division, the apex body CCFI argues that ‘it is scientifically incorrect to allege that pesticides use makes agricultural lands to turn barren’
The company’s net profit rose 57% from Rs 201 crore to Rs 316 crore in Q2FY21 when compared with CPLY
The company's net sales reached Rs. 1,620 crore, showing a growth of 4% over the same period last year
Jubilant Life Sciences has acquired 25% stake in SOFIE Biosciences, USA
Sales for the third quarter were $6,855 million, 2% below prior year
Subscribe To Our Newsletter & Stay Updated
